JNCCN-360

Editor:

David S. Ettinger, MD

Advertisement

Advertisement

A Patient’s Story: NCCN Guidelines for Patients® Helped Me Ask The Right Questions

Mark G. Kris, MD, on NSCLC: Juggling Sequence and Agent Choices

Leora Horn, MD, on NSCLC: The Path Forward for ALK Inhibitors and Immunotherapy

Recent

ASCO 2018: Potential New Standard of Care in Pembrolizumab Combination for Advanced Squamous NSCLC

Expanded Indication for Pemetrexed in Combination Treatment of Metastatic NSCLC

ASCO 2018: Final Overall Survival Results With Dacomitinib vs. Gefitinib in NSCLC

ASCO 2018: Can Genome-Wide Sequencing Assays Detect Early-Stage Lung Cancer?

Published

Medical Literature

Immune Stimulant in Combination With Nivolumab for Metastatic Lung Cancer

Efficacy of Immunotherapy for Lung Cancer: Does Gender Matter?

Risk of Brain Metastases in Patients With NSCLC

Updated ASTRO Guideline Focuses on Palliative Radiotherapy for Lung Cancer

Ongoing

Proceedings from the 15th Annual Winter Lung Cancer Conference

Sustaining Change in Quality Improvement for NSCLC – Part 3

Reflecting on Recent Evidence With an Eye to the Future of Lung Cancer Management

Effects of Early Integrated Palliative Care on Caregivers of Patients with Lung and Gastrointestinal Cancer: A Randomized Clinical Trial

Available

Clinical Trials

Mayo Clinic Cancer Center

Fred and Pamela Buffett Cancer Center

Fox Chase Cancer Center

Vanderbilt-Ingram Cancer Center

Sections

NCCN Resources

Copyright © 2018 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.